Aim We investigated the outcomes of interdisciplinary drug therapy interventions by pharmacists among older residents of special elderly nursing homes. Methods The study was designed as a non‐randomized, parallel‐group, controlled study. Four nursing homes were allocated in a 1:1 ratio to an intervention group (IG) or control group (CG). The participants of the study were residents taking five or more medications. The nursing homes in the IG were each visited by one pharmacist, who was charged with looking for potential problems in drug therapy. Activities in the CG were carried out as usual. The intervention period was 6 months. The primary end‐points were the incidences of potentially inappropriate medication (PIM) and falls. The mean difference and proportion of participants were compared between groups. Results Data from 28 participants in the IG and 27 participants in the CG were analyzed. The number of PIM decreased from 2.64 at baseline to 2.39 after 6 months in the IG (P = 0.032). The proportion of participants in whom the use of PIM was reduced without problems was 17.9% in the IG and 3.7% in the CG (P = 0.094). The mean number of falls was 0.04 in the IG and 0.41 in the CG (P = 0.033). Falls occurred in 3.6% of participants in the IG and 22.2% of participants in the CG (P = 0.043). Conclusions The results suggested a trend toward fewer PIM and falls in the IG. Geriatr Gerontol Int 2019; ••: ••–••.
The current study aimed to examine the outcomes of pharmacists' involvement with elderly people in special nursing homes. We analyzed 58 cases involving regular visits by community pharmacists to 41 residents. The residents' mean age was 87.8±6.9 years, and 68.3% were prescribed 6 or more types of medication. Antipsychotic and insomnia medication was taken by 24.4% and 31.8% of residents, respectively. Pharmaceutical consultation following medication use accounted for 60.3% of pharmacists' involvement with residents. The outcomes of these consultations included improvements in prescription content; the identification and prevention of adverse drug events; improvement in activities of daily living; and improvement in test results, sleep, and urination/bowel control. The results also suggested that pharmacists' intervention reduced drug costs. Information that facilitated involvement was most frequently acquired via conversations (67.2%) and conferences (24.1%) in the facilities. The most common information sources were care workers (72.4%), followed by nurses (37.9%), physicians (6.9%), and functional training instructors (6.9%). Information was also acquired from patients (3.4%) and their family members (5.2%). The findings indicated that regular visits by pharmacists to facilities for elderly people and conversations between residents, their family members, and physicians, nurses and various other professionals improved various pharmacotherapy outcomes.
This survey aimed to examine how patient-pharmacist communication using the drug proˆle book relates patient's behavior regarding its use. Among patients who visited one of theˆve pharmacies during the 4 months between July and October of 2013, 245 patients who had been prescribed antihypertensives were asked to complete a questionnaire. Items included patient attributes, whether the patient thought the drug proˆle book was useful to them (``sense of utility''), whether the patient has ever been questioned by a pharmacist while showing the drug proˆle book (``experience of being questioned by a pharmacist while showing the drug proˆle book''), and whether the patient has ever shown the drug proˆle book to the physician (``experience of showing the drug proˆle book to the physician''). In addition, pharmacists counted the frequency of patients bringing the drug proˆle book, and if so, the frequency of the sticker a‹x during the last 5 visits. 34.3% of responding patients answered that they had the``experience of being questioned while showing the drug proˆle book''. Response rates of``frequency of bringing the drug proˆle book'',``sense of utility'', and``experience of showing the drug proˆle book to the physician'' in the group with``experience of being questioned while showing the drug proˆle book'' were signiˆcantly higher than those in the group without such experience. This survey indicated that experience of being questioned by a pharmacist while showing the drug proˆle book related patient's behavior regarding its use.
We investigated the possibility that having pharmacists give asthma patients informational sheets on climate and environmental changes at insurance pharmacies during patient counseling might prevent the worsening of asthma symptoms. Patients with hyperlipidemia were comparative subjects. We created informational sheets about climate and environmental changes and their in‰uence on asthma. During patient counseling, pharmacists gave them to all asthma patients who visited insurance pharmacies over a period of 2 months, between November and December 2017. Based on previous studies, we called days which showed certain climate or environmental changes as compared to the previous daỳ`c hange days''. We compared the number of visiting patients on change days after preventative information was provided (between January and March 2018) with the number before information was provided (between January and March 2017). In addition, we compared those numbers with the number of patients who visited the target pharmacies between January and March 2016 in order to examine the in‰uence of yearly climate change. The same procedure was used with hyperlipidemic patients. The number of visiting asthma patients after information was provided signiˆcantly decreased (5.1 ± 2.1, p = 0.03) compared with the number before information was provided, between January and March 2017 (6.1 ± 2.8). The number of aforementioned visits compared to those between January and March 2016 also signiˆcantly decreased (p = 0.01). Our results suggest that preventative information about climate and environmental changes provided by pharmacists during patient counseling might in‰uence the number of asthma patient visits and prevent the exacerbation of their symptoms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.